Company: SHPH
Filing Date: 2025-02-28
Form Type: 8-K
Source: 0001493152-25-008742
Chunk: 4

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-28
Form: 8-K
Item: Item 2.03
Chunk 4
---
                                                         
                                                                                                                                                   
      No.                                                                                                                                          
     10.1      Revolving Loan Agreement, dated February 28, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Bowery Consulting Group Inc.  
     10.2      Revolving Note, dated February 28, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Bowery Consulting Group Inc.            
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                                                                               

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                 
  By:                                 /s/                 
  Name:                               Anatoly             
  Title:                              Chief